June Sherie Almenoff Avalo Therapeutics, Inc. (AVTX) insider trading activity

June Sherie Almenoff is Director of Avalo Therapeutics, Inc.. Currently has a direct ownership of 3,167 shares of AVTX, which is worth approximately $15,581. The most recent transaction as insider was on Mar 28, 2025, when has been sold 3,167 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.17K

0% 3M change

n/a 12M change

Total Value Held $15,581

June Sherie Almenoff Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 28 2025	BUY Exercise of conversion of derivative security	-	3,167 Added 50.0%	3,167 Common Stock

Also insider at

TENX

TENAX THERAPEUTICS, INC. Healthcare

BCLI

BRAINSTORM CELL THERAPEUTICS INC. Healthcare

Director

ATNM

Actinium Pharmaceuticals, Inc. Healthcare

Director

JSA